OSE Immunotherapeutics (XPAR:OSE) FCF Margin % : -924.86% (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is OSE Immunotherapeutics FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. OSE Immunotherapeutics's Free Cash Flow for the six months ended in Dec. 2023 was €-8.04 Mil. OSE Immunotherapeutics's Revenue for the six months ended in Dec. 2023 was €0.87 Mil. Therefore, OSE Immunotherapeutics's FCF Margin % for the quarter that ended in Dec. 2023 was -924.86%.

As of today, OSE Immunotherapeutics's current FCF Yield % is -12.60%.

The historical rank and industry rank for OSE Immunotherapeutics's FCF Margin % or its related term are showing as below:

XPAR:OSE' s FCF Margin % Range Over the Past 10 Years
Min: -116425 Med: -101.22 Max: 170.76
Current: -887.47

During the past 12 years, the highest FCF Margin % of OSE Immunotherapeutics was 170.76%. The lowest was -116425.00%. And the median was -101.22%.

XPAR:OSE's FCF Margin % is ranked worse than
74.23% of 1044 companies
in the Biotechnology industry
Industry Median: -146.375 vs XPAR:OSE: -887.47

OSE Immunotherapeutics FCF Margin % Historical Data

The historical data trend for OSE Immunotherapeutics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OSE Immunotherapeutics FCF Margin % Chart

OSE Immunotherapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

33.90

-189.67

-39.50

-101.22

-897.89

OSE Immunotherapeutics Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial															-21.16	-12.93	-729.53	-863.55	-924.86

Competitive Comparison of OSE Immunotherapeutics's FCF Margin %

For the Biotechnology subindustry, OSE Immunotherapeutics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OSE Immunotherapeutics's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OSE Immunotherapeutics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where OSE Immunotherapeutics's FCF Margin % falls into.

OSE Immunotherapeutics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

OSE Immunotherapeutics's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-19.996	/	2.227
	=	-897.89 %

OSE Immunotherapeutics's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-8.037	/	0.869
	=	-924.86 %

OSE Immunotherapeutics FCF Margin % Related Terms

Thank you for viewing the detailed overview of OSE Immunotherapeutics's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

OSE Immunotherapeutics (XPAR:OSE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OSE Immunotherapeutics SA (XPAR:OSE) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

6OP:Germany

Address

22, Boulevard Benoni Goullin, Nantes, FRA, 44200

Website

http://www.ose-immuno.com

OSE Immunotherapeutics SA is a France-based biotechnology company focused on the development of immunotherapies for immune activation and regulation in the fields of immuno-oncology and autoimmune diseases. The product portfolio of the company comprises Tedopi, OSE-172, OSE-703, FR104 and OSE-127.

OSE Immunotherapeutics (XPAR:OSE) Headlines

No Headlines